25 results
424B4
WINT
Windtree Therapeutics Inc
20 Apr 23
Prospectus supplement with pricing info
6:03pm
of these product candidates becomes more widespread if they receive regulatory approval, illnesses, injuries, discomforts and other adverse events that were … costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials or other work-related injuries
424B4
keijo2ibrnxu2sm
21 May 20
Prospectus supplement with pricing info
6:04am
8-K
EX-10.1
m4x7kt9 jld0z
21 Dec 18
Windtree Therapeutics and CVie Therapeutics Announce Merger to Create a Global Acute Care Company Targeting Cardiovascular and Respiratory Diseases
5:28pm
424B5
i0auqwc1l 539l
21 Jul 15
Prospectus supplement for primary offering
12:00am